Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CASIC Builder™ was developed as a result of research conducted through an NIH project SBIR. Initially focused on adherence assessments for individuals living with HIV, the program has since broadened its scope to evaluate factors related to depression, substance and alcohol abuse, as well as sexual risk behaviors. Currently, it serves as a robust and user-friendly tool for creating questionnaires, managing research studies, and facilitating clinical applications. The software's capacity to inquire about a patient's medication regimen has made it valuable in studies concerning adherence to heart medications and opioid prescriptions. Its adaptability has also enabled its utilization in a Brazilian research project that required sign language videos for participants who are deaf. CASIC Builder™ can be accessed with or without its specialized medication components. Since its launch over a decade ago, we have aimed to create a browser-based platform that is effective for complex studies and diverse patient groups while ensuring a straightforward user experience. This commitment to accessibility and flexibility continues to drive enhancements in the software's capabilities.
Description
Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
$795 one-time payment
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
West Portal Software
Country
United States
Website
www.westportal.com
Vendor Details
Company Name
Unlearn
Country
United States
Website
www.unlearn.ai/
Product Features
Survey
Custom Survey URLs
Data Analysis Tools
Email Marketing
Mobile Survey
Offline Response Collection
Paper Survey
Question Branching
Question Library
Site Intercept Survey
Skip Logic
Supports Audio / Images / Video
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning